BMS, GRYT Health collaborate on patient advocacy platform

"Pharmaceutical firm Bristol Myers Squibb (BMS) and digital oncology company GRYT Health have released the Advocacy Exchange patient platform. Building upon the existing COVID Advocacy Exchange, the technology is intended to bring together advocacy organizations, patients, and life-sciences leaders to exchange information, foster dialogue, and share best practices."